Marinus Pharmaceuticals reported $-36673000 in EBITDA for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -33.14M 79.36M
ALKERMES ALKS:US $ -15.07M 7.68M
Amgen AMGN:US $ 3004M 337M
Aptinyx Inc APTX:US $ -17005000 2.27M
Biogen BIIB:US $ 1075.7M 401M
Eisai 4523:JP Y 17237M 28829M
Enanta Pharmaceuticals ENTA:US $ -31.82M 1.2M
Esperion Therapeutics ESPR:US $ -52226000 9.39M
Gilead Sciences GILD:US $ 2585M 837M
Intercept Pharmaceuticals ICPT:US $ -10.87M 0.98M
Intra Cellular Therapies ITCI:US $ -87.75M 15.26M
Marinus Pharmaceuticals MRNS:US $ -36.67M 20.05M
Minerva Neurosciences NERV:US $ -6.96M 1.02M
Neurocrine Biosciences NBIX:US $ 58.6M 52.2M
Ptc Therapeutics PTCT:US $ -63.18M 2.97M
Regeneron Pharmaceuticals REGN:US $ 1381.3M 20.4M
Sarepta Therapeutics SRPT:US $ -201.24M 125.08M
Supernus Pharmaceuticals SUPN:US $ 31.99M 8.66M
Vertex Pharmaceuticals VRTX:US $ 1156.6M 87.3M
YTE INCY:US $ 276.8M 132.69M